Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Capricor Therapeutics, Inc. (CAPR) had Return on Tangible Equity of -12.18% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-33.94M |
|
-- |
|
-- |
|
$36.77M |
|
$-36.77M |
|
$2.83M |
|
$-33.94M |
|
$-33.86M |
|
$-33.94M |
|
$-33.94M |
|
$-33.94M |
|
$-33.86M |
|
$-36.77M |
|
$-36.60M |
|
57.43M |
|
57.43M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$283.09M |
|
$28.50M |
|
$43.19M |
|
$326.28M |
|
$33.64M |
|
-- |
|
$13.94M |
|
$47.58M |
|
$278.70M |
|
$278.70M |
|
$278.70M |
|
57.66M |
|
| Cash Flow Statement Financials | |
$-29.25M |
|
$-154.64M |
|
$1.47M |
|
$287.85M |
|
$105.42M |
|
$-182.43M |
|
$5.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.18% |
|
|
Return on Tangible Equity |
-12.18% |
-10.40% |
|
-12.18% |
|
$4.83 |
|
$-0.70 |
|
$-0.51 |
|